Revised medical criteria for evaluating hematological disorders. Final rules.
Federal Register
|April 23, 2015
Summary
The Social Security Administration is updating criteria for evaluating hematological disorders in adults and children. These revisions incorporate medical advances and public feedback for disability claims.
Area of Science:
- Medical and Social Security Law
- Hematology
- Disability Evaluation
Background:
- The Listing of Impairments (listings) is used to evaluate disability claims.
- Hematological disorders are a key area for disability assessment.
- Current criteria require updating based on medical and societal changes.
Purpose of the Study:
- To revise the criteria for evaluating hematological disorders in adults and children.
- To align disability evaluation with current medical knowledge and treatment.
- To incorporate adjudicative experience and public input.
Main Methods:
- Review of existing Listing of Impairments criteria.
- Consideration of advances in hematological diagnosis and treatment.
- Analysis of public comments received on proposed rule changes.
Main Results:
- Updated criteria for evaluating hematological disorders.
- Revised guidelines for disability claims involving blood disorders.
- Improved alignment of disability evaluation with current medical standards.
Conclusions:
- The revised criteria will enhance the accuracy and fairness of disability evaluations for hematological disorders.
- These updates reflect a commitment to incorporating medical advancements and public input.
- The changes aim to improve the evaluation process for individuals with blood-related conditions.
More Related Videos
12:05Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
12.6K
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.9K
Related Concept Videos
Regulation of Hematopoietic Stem Cells
4.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K
Bone Marrow Sampling and Transplants
2.7K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.7K
Disorders of Erythrocytes
2.9K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.9K
Hematopoiesis
10.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
10.2K
